1. Home
  2. GLP vs GLPG Comparison

GLP vs GLPG Comparison

Compare GLP & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLP
  • GLPG
  • Stock Information
  • Founded
  • GLP 2005
  • GLPG 1999
  • Country
  • GLP United States
  • GLPG Belgium
  • Employees
  • GLP N/A
  • GLPG N/A
  • Industry
  • GLP Oil Refining/Marketing
  • GLPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLP Energy
  • GLPG Health Care
  • Exchange
  • GLP Nasdaq
  • GLPG Nasdaq
  • Market Cap
  • GLP 1.8B
  • GLPG 2.0B
  • IPO Year
  • GLP 2005
  • GLPG 2005
  • Fundamental
  • Price
  • GLP $51.85
  • GLPG $33.29
  • Analyst Decision
  • GLP Hold
  • GLPG Sell
  • Analyst Count
  • GLP 1
  • GLPG 4
  • Target Price
  • GLP $56.00
  • GLPG $25.33
  • AVG Volume (30 Days)
  • GLP 34.0K
  • GLPG 233.1K
  • Earning Date
  • GLP 08-06-2025
  • GLPG 07-23-2025
  • Dividend Yield
  • GLP 5.74%
  • GLPG N/A
  • EPS Growth
  • GLP 16.18
  • GLPG N/A
  • EPS
  • GLP 3.13
  • GLPG N/A
  • Revenue
  • GLP $17,610,371,000.00
  • GLPG $311,493,731.00
  • Revenue This Year
  • GLP $38.58
  • GLPG $0.78
  • Revenue Next Year
  • GLP $17.34
  • GLPG N/A
  • P/E Ratio
  • GLP $16.59
  • GLPG N/A
  • Revenue Growth
  • GLP 6.04
  • GLPG 18.32
  • 52 Week Low
  • GLP $37.00
  • GLPG $22.36
  • 52 Week High
  • GLP $60.00
  • GLPG $33.10
  • Technical
  • Relative Strength Index (RSI)
  • GLP 48.60
  • GLPG 79.17
  • Support Level
  • GLP $50.91
  • GLPG $30.75
  • Resistance Level
  • GLP $52.68
  • GLPG $30.78
  • Average True Range (ATR)
  • GLP 1.22
  • GLPG 0.64
  • MACD
  • GLP -0.04
  • GLPG 0.31
  • Stochastic Oscillator
  • GLP 60.70
  • GLPG 93.78

About GLP Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: